Epiterna

Epalinges, Switzerland

Epiterna is a biotechnology company that focuses on long-term medicines for humans and animals.

$11.0M raised

Aug 2023

Corporate Round

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Epiterna raised?

Epiterna has raised $11.0M in total funding. The most recent round was Corporate Round. The last funding was announced in August 2023.

Who are Epiterna's investors?

Epiterna's investors include Prima Materia.

Where is Epiterna headquartered?

Epiterna is headquartered in Epalinges, Switzerland.

What does Epiterna do?

Epiterna is a biotechnology company that focuses on long-term medicines for humans and animals.

What stage is Epiterna at?

Epiterna is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 1, 2023.

MLA

"Epiterna — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/epiterna. Accessed July 2, 2026.

APA

VCBacked. (2023). Epiterna — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/epiterna

Wikipedia (cite web)

{{cite web |title=Epiterna — Funding & Investors |url=https://www.vcbacked.co/company/epiterna |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 1, 2023.